Spruce Street Capital LP
30 holdingsFiling period: 2026-06-30Current AUM: $433.7Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | — | Kiniksa Pharmaceuticals Intl | 918.1K | $58.7M | $58.7M | 13.54% | +157.0K | 2026-06-30 |
| 2 | RLAY | Relay Therapeutics Inc | 2.98M | $55.8M | $54.1M | 12.47% | -- | 2026-06-30 |
| 3 | LBRX | LB Pharmaceuticals Inc | 1.38M | $44.7M | $54.1M | 12.48% | -- | 2026-06-30 |
| 4 | RLMD | Relmada Therapeutics Inc | 6.39M | $44.2M | $20.6M | 4.76% | +129.2K | 2026-06-30 |
| 5 | ANRO | Alto Neuroscience Inc | 1.35M | $35.7M | $29.9M | 6.90% | +27.8K | 2026-06-30 |
| 6 | DNTH | Dianthus Therapeutics Inc | 354.8K | $34.6M | $28.1M | 6.49% | -18,458 | 2026-06-30 |
| 7 | — | Alkermes PLC | 543.9K | $28.5M | $28.5M | 6.57% | +225.9K | 2026-06-30 |
| 8 | SVRA | Savara Inc | 3.45M | $21.3M | $15.6M | 3.60% | +69.4K | 2026-06-30 |
| 9 | PCVX | Vaxcyte Inc | 306.0K | $17.8M | $18.4M | 4.23% | +60.3K | 2026-06-30 |
| 10 | ELVN | Enliven Therapeutics Inc | 329.0K | $16.7M | $13.7M | 3.15% | -- | 2026-06-30 |
| 11 | ENTA | Enanta Pharmaceuticals Inc | 1.09M | $15.9M | $13.1M | 3.01% | +156.1K | 2026-06-30 |
| 12 | CATX | Perspective Therapeutics Inc | 3.69M | $12.6M | $4.5M | 1.03% | +1.07M | 2026-06-30 |
| 13 | — | Inflarx NV | 5.35M | $12.0M | $12.0M | 2.76% | -- | 2026-06-30 |
| 14 | SRZN | Surrozen Inc | 432.0K | $11.2M | $11.8M | 2.72% | -- | 2026-06-30 |
| 15 | ALMS | Alumis Inc | 392.6K | $11.0M | $2.6M | 0.59% | -- | 2026-06-30 |
| 16 | IPSC | Century Therapeutics Inc | 4.06M | $9.9M | $5.8M | 1.33% | -- | 2026-06-30 |
| 17 | NERV | Minerva Neurosciences Inc | 1.66M | $9.2M | $3.6M | 0.84% | -- | 2026-06-30 |
| 18 | SABS | SAB Biotherapeutics Inc | 2.20M | $8.6M | $6.1M | 1.41% | -- | 2026-06-30 |
| 19 | ANTX | AN2 Therapeutics Inc | 1.66M | $8.0M | $6.0M | 1.39% | -- | 2026-06-30 |
| 20 | ERAS | Erasca Inc | 422.5K | $7.7M | $6.3M | 1.46% | -- | 2026-06-30 |
| 21 | IKT | Inhibikase Therapeutics Inc | 3.58M | $7.3M | $5.4M | 1.26% | -- | 2026-06-30 |
| 22 | — | Research Alliance Corp III | 500.0K | $5.3M | $5.3M | 1.23% | -- | 2026-06-30 |
| 23 | — | Helix Acquisition Corp III | 500.0K | $5.3M | $5.3M | 1.23% | -- | 2026-06-30 |
| 24 | ZLAB | Zai Lab Ltd | 279.1K | $5.3M | $6.8M | 1.57% | -- | 2026-06-30 |
| 25 | ACHV | Achieve Life Science Inc | 736.6K | $4.8M | $4.8M | 1.11% | -- | 2026-06-30 |
← Scroll →
Page 1 of 2